ArticleAnnals of hematology2021

Direct oral anticoagulants (DOAC) for prevention of recurrent arterial or venous thromboembolic events (ATE/VTE) in myeloproliferative neoplasms.

Karlo Huenerbein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.